You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Author Index Volume 5 (2015)

The issue number is given in front of the pagination

Aarsland, D. and M.G. Kramberger, Neuropsychiatric Symptoms in Parkinson’s Disease (3) 659-667

Aarsland, D., see Skogseth, R.E. (4) 783-792

Abbott, S.K., A.M. Jenner, A.S. Spiro, M. Batterham, G.M. Halliday and B. Garner, Fatty Acid Composition of the Anterior Cingulate Cortex Indicates a High Susceptibility to Lipid Peroxidation in Parkinson’s Disease (1) 175-185

Abreu, D., see Reimão, S. (3) 561-567

Achey, M.A., see Dorsey, E.R. (3) 505-515

Ács, P., see Deli, G. (2) 361-368

Adler, C.H., see Caviness, J.N. (1) 117-124

Adler, C.H., see Lin, T.P. (1) 125-130

Adler, J.S., see Lin, T.P. (1) 125-130

Agid, Y., The Concept of Subconsciousness in Alzheimer’s and Parkinson’s Diseases (3) 643-645

Ahmad, S.H., see Dorsey, E.R. (3) 505-515

Aita, S., see Cohen, M.L. (2) 351-359

Akbar, F., see Price, C.C. (4) 893-905

Al-Jawad, A., see Ferreira, J.J. (2) 281-290

Allen, N.E., N. Moloney, V. van Vliet and C.G. Canning, The Rationale for Exercise in the Management of Pain in Parkinson’s Disease (2) 229-239

Allen, N.E., see Almeida, L.R.S. (4) 855-864

Almeida, L.R.S., C. Sherrington, N.E. Allen, S.S. Paul, G.T. Valenca, J. Oliveira-Filho and C.G. Canning, Disability is an Independent Predictor of Falls and Recurrent Falls in People with Parkinson’s Disease Without a History of Falls: A One-Year Prospective Study (4) 855-864

Alvarado-Bolaños, A., A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Llorens-Arenas, H. Calderón-Fajardo, R. Millán-Cepeda, R. Leal-Ortega, I. Estrada-Bellmann and C. Zuñiga-Ramírez, Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson’s Disease (3) 541-548

Armstrong, R.A., Oculo-Visual Dysfunction in Parkinson’s Disease (4) 715-726

Aronsson, P., see Mitra, R. (2) 301-311

Aschermann, Z., see Deli, G. (2) 361-368

Ashkan, K., see Ughratdar, I. (3) 483-496

Aubertin-Leheudre, M., see Daneault, J.-F. (1) 85-93

Auburger, G., see Brehm, N. (3) 595-604

Auvinen, P., see Scheperjans, F. (2) 255-262

Avilés, E., see Stephenson, D. (3) 581-594

Baig, F., see Lawton, M. (2) 269-279

Bain, L.J., see Stephenson, D. (3) 581-594

Bajaj, N., see Malek, N. (4) 947-959

Baker, L., see Simon, D.K. (4) 731-736

Balás, I., see Deli, G. (2) 361-368

Balcer, L.J., see Lin, T.P. (1) 125-130

Balloy, G., see Preterre, C. (4) 765-772

Barbat-Artigas, S., see Daneault, J.-F. (1) 85-93

Barker, R.A., see Malek, N. (4) 947-959

Barker, R.A., see Yarnall, A.J. (4) 743-747

Barone, P., see Moccia, M. (4) 913-924

Bar-Shira, A., see Simon-Tov, S. (3) 525-531

Barton, B., see Westbay, L.C. (3) 497-504

Batterham, M., see Abbott, S.K. (1) 175-185

Bega, D., S. Kim, Y. Zhang, J. Elm, J. Schneider, R. Hauser, A. Fraser and T. Simuni on behalf of the NET-PD LS1 Investigators, Predictors of Functional Decline in Early Parkinson’s Disease: NET-PD LS1 Cohort (4) 773-782

Beijer, T.R., see Brodie, M.A.D. (1) 105-116

Béland, S.-G., R.B. Postuma, V. Latreille, J.-A. Bertrand, M. Panisset, S. Chouinard, C. Wolfson and J.-F. Gagnon, Observational Study of the Relation between Parkinson’s Disease and Sleep Apnea (4) 805-811

Belden, C.M., see Caviness, J.N. (1) 117-124

Benesh, J., see Slevin, J.T. (1) 165-174

Ben-Shlomo, Y., see Lawton, M. (2) 269-279

Ben-Shlomo, Y., see Malek, N. (4) 947-959

Ben-Shlomo, Y., see Stephenson, D. (3) 581-594

Bergquist, F., see Mitra, R. (2) 301-311

Bertrand, J.-A., see Béland, S.-G. (4) 805-811

Bettiol, S.S., T.C. Rose, C.J. Hughes and L.A. Smith, Alcohol Consumption and Parkinson’s Disease Risk: A Review of Recent Findings (3) 425-442

Bhattaram, A., see Stephenson, D. (3) 581-594

Bichon, A., see Sierra, M. (3) 625-636

Biemiller, R.A., see Dorsey, E.R. (3) 505-515

Biglan, K.M., see Dorsey, E.R. (3) 505-515

Bliwise, D.L., see Scullin, M.K. (1) 49-54

Bloem, B.R., see Canoy, M. (3) 575-580

Bloem, B.R., see Domingos, J.M. (3) 453-469

Bloem, B.R., see Haaxma, C.A. (4) 847-853

Bloem, B.R., see Hassan, A. (2) 313-319

Bloem, B.R., see Nonnekes, J. (1) 43-47

Bloem, B.R., see van der Eijk, M. (4) 937-945

Bloem, B.R., see Zach, H. (3) 471-474

Bloem, B.R., see Zach, H. (4) 727-729

Bloem, B.R., see Zhao, Y. (2) 369-378

Bohnen, N.I., see Fasano, A. (2) 241-254

Bonizzoni, E., see Cattaneo, C. (3) 475-481

Borden, A., see Le Goff, F. (1) 95-104

Borenstein, A.R., see Sullivan, K.L. (4) 813-820

Borm, G.F., see Haaxma, C.A. (4) 847-853

Bosnyák, E., see Deli, G. (2) 361-368

Bowers, D., see Price, C.C. (4) 893-905

Boyd, J.T., see Parashos, S.A. (1) 67-73

Brandt, J., see Cohen, M.L. (2) 351-359

Breen, D.P., see Yarnall, A.J. (4) 743-747

Breen, K., see Stephenson, D. (3) 581-594

Brehm, N., K. Rau, A. Kurz, S. Gispert and G. Auburger, Age-Related Changes of 14-3-3 Isoforms in Midbrain of A53T-SNCA Overexpressing Mice (3) 595-604

Bresner, C., see Malek, N. (4) 947-959

Brodie, M.A.D., R.T. Dean, T.R. Beijer, C.G. Canning, S.T. Smith, J.C. Menant and S.R. Lord, Symmetry Matched Auditory Cues Improve Gait Steadiness in Most People with Parkinson’s Disease but not in Healthy Older People (1) 105-116

Bronnick, K., see Skogseth, R.E. (4) 783-792

Brooks, D., see Yarnall, A.J. (4) 743-747

Brooks, D.W., see Rocker, C. (1) 55-66

Brownlee, H.J., see Sullivan, K.L. (4) 813-820

Brundin, P., see George, S. (3) 413-424

Bull, M.T., see Dorsey, E.R. (3) 505-515

Burn, D., see Stephenson, D. (3) 581-594

Burn, D.J., see Malek, N. (4) 947-959

Burn, D.J., see Yarnall, A.J. (4) 743-747

Burnett-Zeigler, I., see Westbay, L.C. (3) 497-504

Burré, J., The Synaptic Function of α-Synuclein (4) 699-713

Butler, J.S., see Fearon, C. (4) 925-936

Cabrera-Zubizarreta, A., see Lucas-Jiménez, O. (4) 793-804

Calderón-Fajardo, H., see Alvarado-Bolaños, A. (3) 541-548

Campos, J., see Reimão, S. (3) 561-567

Canning, C.G., see Allen, N.E. (2) 229-239

Canning, C.G., see Almeida, L.R.S. (4) 855-864

Canning, C.G., see Brodie, M.A.D. (1) 105-116

Canoy, M., M.J. Faber, M. Munneke, W. Oortwijn, M.J. Nijkrake and B.R. Bloem, Hidden Treasures and Secret Pitfalls: Application of the Capability Approach to ParkinsonNet (3) 575-580

Cao, L., see Westbay, L.C. (3) 497-504

Capitanio, F., see Serrano, J.A. (1) 187-196

Cappelletti, L., see Dorsey, E.R. (3) 505-515

Cappelletti, L., see Rocker, C. (1) 55-66

Carlsson, T., see Mitra, R. (2) 301-311

Carnicella, S., see Sierra, M. (3) 625-636

Castrioto, A., see Sierra, M. (3) 625-636

Cattaneo, C., R. La Ferla, E. Bonizzoni and M. Sardina, Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson’s Disease: A Post-Hoc Analysis (3) 475-481

Cavanaugh, J.T., see Duncan, R.P. (1) 131-139

Caviness, J.N., J.G. Hentz, C.M. Belden, H.A. Shill, E.D. Driver-Dunckley, M.N. Sabbagh, J.J. Powell and C.H. Adler, Longitudinal EEG Changes Correlate with Cognitive Measure Deterioration in Parkinson’s Disease (1) 117-124

Cervantes-Arriaga, A., see Alvarado-Bolaños, A. (3) 541-548

Chabardes, S., see Sierra, M. (3) 625-636

Charles, D., see Tramontana, M.G. (1) 151-163

Chatamra, K., see Slevin, J.T. (1) 165-174

Chaudhuri, K.R., see Fauser, M. (4) 737-741

Cheong, Y.W., see Tan, A.H. (4) 865-879

Chesselet, M.-F., see Magen, I. (3) 669-680

Chou, K.L., see Parashos, S.A. (1) 67-73

Chouinard, S., see Béland, S.-G. (4) 805-811

Chowdhury, S., see Dorsey, E.R. (3) 505-515

Chowdhury, S., see Rocker, C. (1) 55-66

Chung, A., see Magen, I. (3) 669-680

Ciucci, M.R., see Kelm-Nelson, C.A. (4) 749-763

Clark-Matott, J., see Simon, D.K. (4) 731-736

Coelho MD, M., see Domingos, J.M. (3) 453-469

Coelho, M., see Reimão, S. (3) 561-567

Cohen, M.L., N.A. Schwab, C.C. Price and K.M. Heilman, Impaired Switching from Self-Prepared Actions in Mild Parkinson Disease (4) 961-970

Cohen, M.L., S. Aita, Z. Mari and J. Brandt, The Unique and Combined Effects of Apathy and Depression on Cognition in Parkinson’s Disease (2) 351-359

Comella, C.L., see Lamotte, G. (1) 21-41

Corbillé, A.-G., see Preterre, C. (4) 765-772

Corcos, D.M., see Lamotte, G. (1) 21-41

Cronin, R., see Lin, T.P. (1) 125-130

Cronin-Golomb, A., see Seichepine, D.R. (1) 75-83

Crosson, B., see Ellis, C. (2) 403-411

Cusumano, J.P., see Sterling, N.W. (1) 141-150

Dai, L., see Parashos, S.A. (1) 67-73

Damier, P., Why do Parkinson’s Disease Patients Sometimes Make Wrong Decisions? (3) 637-642

Daneault, J.-F., A.F. Sadikot, S. Barbat-Artigas, M. Aubertin-Leheudre, N. Jodoin, M. Panisset and C. Duval, Physical Activity in Advanced Parkinson’s Disease: Impact of Subthalamic Deep Brain Stimulation (1) 85-93

Däuper, J., see Münte, T.F. (3) 613-620

Davidsdottir, S., see Seichepine, D.R. (1) 75-83

Davis, T.L., see Tramontana, M.G. (1) 151-163

Dean, J., see Domingos, J.M. (3) 453-469

Dean, R.T., see Brodie, M.A.D. (1) 105-116

Defebvre, L., see Tard, C. (2) 379-387

Defebvre, L., see Tard, C. (3) 569-574

Deli, G., Z. Aschermann, P. Ács, E. Bosnyák, J. Janszky, B. Faludi, A. Makkos, M. Kovács, S. Komoly, I. Balás, T. Dóczi and N. Kovács, Bilateral Subthalamic Stimulation can Improve Sleep Quality in Parkinson’s Disease (2) 361-368

Delval, A., see Tard, C. (2) 379-387

Delval, A., see Tard, C. (3) 569-574

Demailly, F., see Tard, C. (3) 569-574

Dengler, R., see Münte, T.F. (3) 613-620

Derkinderen, P., see Preterre, C. (4) 765-772

Derrey, S., see Le Goff, F. (1) 95-104

Devick, S., see Lin, T.P. (1) 125-130

Devos, D., see Tard, C. (2) 379-387

DeWitte, S., see Mathur, S. (2) 263-268

Dibble, L.E., see Duncan, R.P. (1) 131-139

Dibble, L.E., see Hayes, H.A. (3) 549-560

Díez-Cirarda, M., see Lucas-Jiménez, O. (4) 793-804

Dinh, D., see Magen, I. (3) 669-680

Dinur, T., see Simon-Tov, S. (3) 525-531

Dirkx, M., see Zach, H. (3) 471-474

Dóczi, T., see Deli, G. (2) 361-368

Domingos, J., see Ferreira, J.J. (2) 281-290

Domingos, J., see Serrano, J.A. (1) 187-196

Domingos, J.M., C. Godinho, J. Dean, M. Coelho MD, A. Pinto, B.R. Bloem and J.J. Ferreira, Cognitive Impairment in Fall-Related Studies in Parkinson’s Disease (3) 453-469

Dorsey, E.R., J.D. Wagner, M.T. Bull, A. Rizzieri, J. Grischkan, M.A. Achey, T. Sherer, S. Chowdhury, C. Meunier, L. Cappelletti, C. Rocker, I.H. Richard, H. Schwarz, G. Kang, S.H. Ahmad, R.A. Biemiller and K.M. Biglan, Feasibility of Virtual Research Visits in Fox Trial Finder (3) 505-515

Dou, Y., see Jiao, Y. (2) 389-401

Dragunow, M., see Yang, P. (4) 821-836

Driver-Dunckley, E.D., see Caviness, J.N. (1) 117-124

Du, G., see Sterling, N.W. (1) 141-150

Dubow, J., see Slevin, J.T. (1) 165-174

Duffen, J., see Ferreira, J.J. (2) 281-290

Duffen, J., see Serrano, J.A. (1) 187-196

Duhamel, A., see Tard, C. (2) 379-387

Dujardin, K., see Tard, C. (2) 379-387

Dujardin, K., see Tard, C. (3) 569-574

Duncan, G.W., see Yarnall, A.J. (4) 743-747

Duncan, R.P., A.L. Leddy, J.T. Cavanaugh, L.E. Dibble, T.D. Ellis, M.P. Ford, K.B. Foreman and G.M. Earhart, Detecting and Predicting Balance Decline in Parkinson Disease: A Prospective Cohort Study (1) 131-139

Dunlop, S.R., see Simon, D.K. (4) 731-736

Duval, C., see Daneault, J.-F. (1) 85-93

Earhart, G.M., see Duncan, R.P. (1) 131-139

Eaton, S., see Slevin, J.T. (1) 165-174

Ebersbach, G., see Fauser, M. (4) 737-741

Egan, S.J., K. Laidlaw and S. Starkstein, Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease (3) 443-451

Ellis, C., B. Crosson, L.J.G. Rothi, M.S. Okun and J.C. Rosenbek, Narrative Discourse Cohesion in Early Stage Parkinson’s Disease (2) 403-411

Ellis, T.D., see Duncan, R.P. (1) 131-139

Elm, J., see Bega, D. (4) 773-782

Elm, J., see Parashos, S.A. (1) 67-73

Elm, J., see Simon, D.K. (4) 731-736

Elmer, L., see Nausieda, P.A. (4) 837-845

Elstein, D., see Simon-Tov, S. (3) 525-531

Emborg, M., see Simon, D.K. (4) 731-736

Erro, R., see Moccia, M. (4) 913-924

Estrada-Bellmann, I., see Alvarado-Bolaños, A. (3) 541-548

Faber, M.J., see Canoy, M. (3) 575-580

Faber, M.J., see van der Eijk, M. (4) 937-945

Factor, S.A., see Scullin, M.K. (1) 49-54

Fairley, J.A., see Scullin, M.K. (1) 49-54

Faludi, B., see Deli, G. (2) 361-368

Fasano, A., T. Herman, A. Tessitore, A.P. Strafella and N.I. Bohnen, Neuroimaging of Freezing of Gait (2) 241-254

Faull, R., see Yang, P. (4) 821-836

Fauser, M., M. Löhle, G. Ebersbach, P. Odin, G. Fuchs, W.H. Jost, K.R. Chaudhuri, R. Koch, NoMoFlu-PD study group and Alexander Storch, Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson’s Disease (4) 737-741

Fearon, C., J.S. Butler, L. Newman, T. Lynch and R.B. Reilly, Audiovisual Processing is Abnormal in Parkinson’s Disease and Correlates with Freezing of Gait and Disease Duration (4) 925-936

Fernandez, H.H., see Slevin, J.T. (1) 165-174

Ferreira, J., see Reimão, S. (3) 561-567

Ferreira, J.J., A.T. Santos, J. Domingos, H. Matthews, T. Isaacs, J. Duffen, A. Al-Jawad, F. Larsen, J.A. Serrano, P. Weber, A. Thoms, S. Sollinger, H. Graessner and W. Maetzler, Clinical Parameters and Tools for Home-Based Assessment of Parkinson’s Disease: Results from a Delphi study (2) 281-290

Ferreira, J.J., see Domingos, J.M. (3) 453-469

Ferreira, J.J., see Reimão, S. (3) 561-567

Ferreira, J.J., see Serrano, J.A. (1) 187-196

Fetter, D., see Le Goff, F. (1) 95-104

Filoteo, J.V., see Pirogovsky-Turk, E. (4) 971-981

Fladby, T., see Skogseth, R.E. (4) 783-792

Foltynie, T., see Malek, N. (4) 947-959

Ford, M.P., see Duncan, R.P. (1) 131-139

Ford, S., see Stephenson, D. (3) 581-594

Foreman, K.B., see Duncan, R.P. (1) 131-139

Fraser, A., see Bega, D. (4) 773-782

Friend, S., see Stephenson, D. (3) 581-594

Fuchs, G., see Fauser, M. (4) 737-741

Gagnon, J.-F., see Béland, S.-G. (4) 805-811

Galetta, S.L., see Lin, T.P. (1) 125-130

Gallacher, J., see Stephenson, D. (3) 581-594

Gardner, G.M., see Silbergleit, A.K. (3) 517-524

Garner, B., see Abbott, S.K. (1) 175-185

Garvan, C., see Price, C.C. (4) 893-905

Gasser, T., Usefulness of Genetic Testing in PD and PD Trials: A Balanced Review (2) 209-215

George, S. and P. Brundin, Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation (3) 413-424

Gerrits, W.L.J., see Zach, H. (4) 727-729

Gil, R.A., see Nausieda, P.A. (4) 837-845

Giladi, N., see Hassan, A. (2) 313-319

Giladi, N., see Simon-Tov, S. (3) 525-531

Gilat, M., see Hall, J.M. (4) 881-891

Gill, C.E., see Tramontana, M.G. (1) 151-163

Gispert, S., see Brehm, N. (3) 595-604

Godinho, C., see Domingos, J.M. (3) 453-469

Goh, K.J., see Tan, A.H. (4) 865-879

Goldstein, F.C., see Scullin, M.K. (1) 49-54

Gonçalves, N., see Reimão, S. (3) 561-567

Gordon, M.F., see Stephenson, D. (3) 581-594

Goselink, R., see Nonnekes, J. (1) 43-47

Graebner, A.K., see Simon, D.K. (4) 731-736

Graessner, H., see Ferreira, J.J. (2) 281-290

Graessner, H., see Serrano, J.A. (1) 187-196

Grischkan, J., see Dorsey, E.R. (3) 505-515

Grosset, D., see Stephenson, D. (3) 581-594

Grosset, K.A., see Malek, N. (4) 947-959

Guan, J., see Yang, P. (4) 821-836

Guedes, L.C., see Reimão, S. (3) 561-567

Gupta, S., see Nausieda, P.A. (4) 837-845

Haak, M., see Nilsson, M.H. (4) 983-992

Haaxma, C.A., M.W.I.M. Horstink, J.C. Zijlmans, W.A.J.G. Lemmens, B.R. Bloem and G.F. Borm, Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson’s Disease (4) 847-853

Hall, C., see Slevin, J.T. (1) 165-174

Hall, J.M., J.M. Shine, C. O’Callaghan, C.C. Walton, M. Gilat, S.L. Naismith and S.J.G. Lewis, Freezing of Gait and its Associations in the Early and Advanced Clinical Motor Stages of Parkinson’s Disease: A Cross-Sectional Study (4) 881-891

Halliday, G.M., see Abbott, S.K. (1) 175-185

Hardy, J., see Malek, N. (4) 947-959

Harrington, D.L., see Pirogovsky-Turk, E. (4) 971-981

Hassan, A., S.S. Wu, P. Schmidt, T. Simuni, N. Giladi, J.M. Miyasaki, B.R. Bloem, I.A. Malaty, M.S. Okun and on behalf of the NPF QII Investigators, The Profile of Long-term Parkinson’s Disease Survivors with 20 Years of Disease Duration and Beyond (2) 313-319

Hauser, R., see Bega, D. (4) 773-782

Hayes, H.A., N. Hunsaker and L.E. Dibble, Implicit Motor Sequence Learning in Individuals with Parkinson Disease: A Meta-Analysis (3) 549-560

Hedera, P., see Tramontana, M.G. (1) 151-163

Heida, T., see Zhao, Y. (2) 369-378

Heilman, K.M., see Cohen, M.L. (4) 961-970

Heldmann, M., see Münte, T.F. (3) 613-620

Helmich, R.C., see Zach, H. (3) 471-474

Hentz, J.G., see Caviness, J.N. (1) 117-124

Hentz, J.G., see Lin, T.P. (1) 125-130

Herman, T., see Fasano, A. (2) 241-254

Ho, N.W.W., see Tan, A.H. (4) 865-879

Hoffmann, R., see Ma, J.K.-Y. (2) 291-299

Horstink, M.W.I.M., see Haaxma, C.A. (4) 847-853

Hsu, A., see Nausieda, P.A. (4) 837-845

Hu, M.T., see Stephenson, D. (3) 581-594

Hu, M.T.M., see Lawton, M. (2) 269-279

Huang, X. see Sterling, N.W. (1) 141-150

Hughes, C.J., see Bettiol, S.S. (3) 425-442

Hunsaker, N., see Hayes, H.A. (3) 549-560

Ibarretxe-Bilbao, N., see Lucas-Jiménez, O. (4) 793-804

Ippolito, D., see Westbay, L.C. (3) 497-504

Isaac, M., see Stephenson, D. (3) 581-594

Isaacs, T., see Ferreira, J.J. (2) 281-290

Isaacs, T., see Mathur, S. (2) 263-268

Isaacs,v, see Serrano, J.A. (1) 187-196

Iwarsson, S., see Jonasson, S.B. (2) 341-349

Iwarsson, S., see Nilsson, M.H. (4) 983-992

Jahanshahi, M., see Williams, I.A. (2) 321-331

Jan, M., see Le Goff, F. (1) 95-104

Janszky, J., see Deli, G. (2) 361-368

Jenner, A.M., see Abbott, S.K. (1) 175-185

Jiao, Y., Y. Dou, G. Lockwood, A. Pani and R.J. Smeyne, Acute Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or Paraquat on Core Temperature in C57BL/6J Mice (2) 389-401

Jodoin, N., see Daneault, J.-F. (1) 85-93

Jonasson, S.B., S. Ullén, S. Iwarsson, J. Lexell and M.H. Nilsson, Concerns About Falling in Parkinson’s Disease: Associations with Disabilities and Personal and Environmental Factors (2) 341-349

Joppich, G., see Münte, T.F. (3) 613-620

Jost, W.H., see Fauser, M. (4) 737-741

Ju, Y.-S., see Kim, Y.E. (3) 605-612

Kaakkola, S., see Scheperjans, F. (2) 255-262

Kamp, C., see Simon, D.K. (4) 731-736

Kang, G., see Dorsey, E.R. (3) 505-515

Kang, S.Y., see Kim, Y.E. (3) 605-612

Kell, S., see Nausieda, P.A. (4) 837-845

Kelm-Nelson, C.A., K.M. Yang and M.R. Ciucci, Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson’s Disease (4) 749-763

Khanna, S., see Nausieda, P.A. (4) 837-845

Khoo, T.K., see Yarnall, A.J. (4) 743-747

Kim, S., see Bega, D. (4) 773-782

Kim, Y.E., S.Y. Kang, H.-I. Ma, Y.-S. Ju and Y.J. Kim, A Visual Rating Scale for the Hummingbird Sign with Adjustable Diagnostic Validity (3) 605-612

Kim, Y.J., see Kim, Y.E. (3) 605-612

Klingelhoefer, L. and H. Reichmann, Parkinson’s Disease and Gastrointestinal Non Motor Symptoms: Diagnostic and Therapeutic Options – A Practise Guide (3) 647-658

Koch, R., see Fauser, M. (4) 737-741

Koetsenruijter, J., see van der Eijk, M. (4) 937-945

Kohrt, W.M., see Lamotte, G. (1) 21-41

Komoly, S., see Deli, G. (2) 361-368

Kong, L., see Sterling, N.W. (1) 141-150

Kong, S.T., see Tan, A.H. (4) 865-879

Konrad, P.E., see Tramontana, M.G. (1) 151-163

Kovacs, G.G., see Pirker, S. (4) 907-912

Kovacs, G.G., see Rahimi, J. (2) 333-340

Kovács, M., see Deli, G. (2) 361-368

Kovács, N., see Deli, G. (2) 361-368

Krack, P., see Sierra, M. (3) 625-636

Kramberger, M.G., see Aarsland, D. (3) 659-667

Kubota, K., see Stephenson, D. (3) 581-594

Kurz, A., see Brehm, N. (3) 595-604

La Ferla, R., see Cattaneo, C. (3) 475-481

Laidlaw, K., see Egan, S.J. (3) 443-451

Lamotte, G., M.R. Rafferty, J. Prodoehl, W.M. Kohrt, C.L. Comella, T. Simuni and D.M. Corcos, Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson’s Disease: A Review (1) 21-41

Larsen, F., see Ferreira, J.J. (2) 281-290

Larsen, F., see Serrano, J.A. (1) 187-196

Latreille, V., see Béland, S.-G. (4) 805-811

Lawson, R.A., see Yarnall, A.J. (4) 743-747

Lawton, M., F. Baig, M. Rolinski, C. Ruffman, K. Nithi, M.T. May, Y. Ben-Shlomo and M.T.M. Hu, Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort (2) 269-279

Lawton, M.A., see Malek, N. (4) 947-959

Le Goff, F., S. Derrey, R. Lefaucheur, A. Borden, D. Fetter, M. Jan, D. Wallon and D. Maltête, Decline in Verbal Fluency After Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease: A Microlesion Effect of the Electrode Trajectory? (1) 95-104

Leal-Ortega, R., see Alvarado-Bolaños, A. (3) 541-548

Leddy, A.L., see Duncan, R.P. (1) 131-139

Lefaucheur, R., see Le Goff, F. (1) 95-104

Lehn, A.C., see Malek, N. (4) 947-959

Lemmens, W.A.J.G., see Haaxma, C.A. (4) 847-853

Letournel, F., see Preterre, C. (4) 765-772

Levy, S.-A., see Price, C.C. (4) 893-905

Lew, S.L.H., see Tan, A.H. (4) 865-879

Lewis, M.M., see Sterling, N.W. (1) 141-150

Lewis, S.J.G., see Hall, J.M. (4) 881-891

LeWitt, P.A., see Silbergleit, A.K. (3) 517-524

Lexell, J., see Jonasson, S.B. (2) 341-349

Lhommée, E., see Sierra, M. (3) 625-636

Lim, C.C., see Tan, A.H. (4) 865-879

Lim, Q.H., see Tan, A.H. (4) 865-879

Lim, S.-Y., see Tan, A.H. (4) 865-879

Limousin, P., see Williams, I.A. (2) 321-331

Lin, T.P., H. Rigby, J.S. Adler, J.G. Hentz, L.J. Balcer, S.L. Galetta, S. Devick, R. Cronin and C.H. Adler, Abnormal Visual Contrast Acuity in Parkinson’s Disease (1) 125-130

Little, M.A., see Stephenson, D. (3) 581-594

Litvan, I., see Pirogovsky-Turk, E. (4) 971-981

Liu, G., see Sterling, N.W. (1) 141-150

Llorens-Arenas, R., see Alvarado-Bolaños, A. (3) 541-548

Lobo, P.P., see Reimão, S. (3) 561-567

Lockwood, G., see Jiao, Y. (2) 389-401

Loh, K.W., see Tan, A.H. (4) 865-879

Löhle, M., see Fauser, M. (4) 737-741

Lord, S.R., see Brodie, M.A.D. (1) 105-116

Lovestone, S., see Stephenson, D. (3) 581-594

Lucas-Jiménez, O., M. Díez-Cirarda, N. Ojeda, J. Peña, A. Cabrera-Zubizarreta and N. Ibarretxe-Bilbao, Verbal Memory in Parkinson’s Disease: A Combined DTI and fMRI Study (4) 793-804

Lynch, T., see Fearon, C. (4) 925-936

Ma, H.-I., see Kim, Y.E. (3) 605-612

Ma, J.K.-Y., C.B. Schneider, R. Hoffmann and A. Storch, Speech Prosody Across Stimulus Types for Individuals with Parkinson’s Disease (2) 291-299

Maetzler, W., see Ferreira, J.J. (2) 281-290

Maetzler, W., see Serrano, J.A. (1) 187-196

Magen, I., E.R. Torres, D. Dinh, A. Chung, E. Masliah and M.-F. Chesselet, Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson’s Disease (3) 669-680

Mahamad, U.A., see Tan, A.H. (4) 865-879

Mahlknecht, P., K. Seppi and W. Poewe, The Concept of Prodromal Parkinson’s Disease (4) 681-697

Makkos, A., see Deli, G. (2) 361-368

Malaty, I.A., see Hassan, A. (2) 313-319

Malek, N., D.M.A. Swallow, K.A. Grosset, M.A. Lawton, S.L. Marrinan, A.C. Lehn, C. Bresner, N. Bajaj, R.A. Barker, Y. Ben-Shlomo, D.J. Burn, T. Foltynie, J. Hardy, H.R. Morris, N.M. Williams, N. Wood and D.G. Grosset on behalf of the PRoBaND clinical consortium, Tracking Parkinson’s: Study Design and Baseline Patient Data (4) 947-959

Maltête, D., see Le Goff, F. (1) 95-104

Marek, K., see Stephenson, D. (3) 581-594

Mari, Z., see Cohen, M.L. (2) 351-359

Mari, Z., see Parashos, S.A. (1) 67-73

Marras, C., see Tan, A.H. (4) 865-879

Marrinan, S.L., see Malek, N. (4) 947-959

Marshall, C., see Rocker, C. (1) 55-66

Martin, A., see Matthews, H. (3) 533-539

Masliah, E., see Magen, I. (3) 669-680

Mathur, S., S. DeWitte, I. Robledo, T. Isaacs and J. Stamford, Rising to the Challenges of Clinical Trial Improvement in Parkinson’s Disease (2) 263-268

Matthews, H., J. Stamford, R. Saha and A. Martin on behalf of the Off-Park survey steering group, Exploring Issues Around Wearing-off and Quality of Life: The OFF-PARK Survey of People with Parkinson’s Disease and their Care Partners (3) 533-539

Matthews, H., see Ferreira, J.J. (2) 281-290

Matthews, H., see Serrano, J.A. (1) 187-196

May, A.T., see Tramontana, M.G. (1) 151-163

May, M.T., see Lawton, M. (2) 269-279

Melki, R., Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases (2) 217-227

Menant, J.C., see Brodie, M.A.D. (1) 105-116

Meunier, C., see Dorsey, E.R. (3) 505-515

Meunier, C.C., see Rocker, C. (1) 55-66

Milenkovic, I., see Rahimi, J. (2) 333-340

Millán-Cepeda, R., see Alvarado-Bolaños, A. (3) 541-548

Mitra, R., P. Aronsson, M. Winder, G. Tobin, F. Bergquist and T. Carlsson, Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson’s Disease (2) 301-311

Miyasaki, J.M., see Hassan, A. (2) 313-319

Moccia, M., B. Mollenhauer, R. Erro, M. Picillo, R. Palladino and P. Barone, Non-Motor Correlates of Smoking Habits in de Novo Parkinson’s Disease (4) 913-924

Modi, N.B., see Nausieda, P.A. (4) 837-845

Molinari, A.L., see Tramontana, M.G. (1) 151-163

Mollenhauer, B., see Moccia, M. (4) 913-924

Mollenhauer, B., see Skogseth, R.E. (4) 783-792

Moloney, N., see Allen, N.E. (2) 229-239

Moreau, C., see Tard, C. (2) 379-387

Moreau, C., see Tard, C. (3) 569-574

Morgado, C., see Reimão, S. (3) 561-567

Morgan, J.C., see Parashos, S.A. (1) 67-73

Morgan, J.C., see Simon, D.K. (4) 731-736

Morris, H.R., see Malek, N. (4) 947-959

Morris, H.R., see Stephenson, D. (3) 581-594

Mortimer, J.A., see Sullivan, K.L. (4) 813-820

Munneke, M., see Canoy, M. (3) 575-580

Munneke, M., see van der Eijk, M. (4) 937-945

Münte, T.F., G. Joppich, J. Däuper, C. Schrader, R. Dengler and M. Heldmann, Random Number Generation and Executive Functions in Parkinson’s Disease: An Event-Related Brain Potential Study (3) 613-620

Naismith, S.L., see Hall, J.M. (4) 881-891

Nausieda, P.A., A. Hsu, L. Elmer, R.A. Gil, J. Spiegel, C. Singer, S. Khanna, R. Rubens, S. Kell, N.B. Modi and S. Gupta, Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson’s Disease: Experience in Clinical Trials (4) 837-845

Neargarder, S., see Seichepine, D.R. (1) 75-83

Neimat, J.S., see Tramontana, M.G. (1) 151-163

Neunlist, M., see Preterre, C. (4) 765-772

Neutel, D., see Reimão, S. (3) 561-567

Newman, L., see Fearon, C. (4) 925-936

Nijhuis, F.A.P., see van der Eijk, M. (4) 937-945

Nijkrake, M.J., see Canoy, M. (3) 575-580

Nilsson, M.H., S. Iwarsson, B. Thordardottir and M. Haak, Barriers and Facilitators for Participation in People with Parkinson’s Disease (4) 983-992

Nilsson, M.H., see Jonasson, S.B. (2) 341-349

Nithi, K., see Lawton, M. (2) 269-279

Nonnekes, J., R. Goselink, V. Weerdesteyn and B.R. Bloem, The Retropulsion Test: A Good Evaluation of Postural Instability in Parkinson’s Disease? (1) 43-47

Nunes, R.G., see Reimão, S. (3) 561-567

O’Callaghan, C., see Hall, J.M. (4) 881-891

Odin, P., see Fauser, M. (4) 737-741

Ojeda, N., see Lucas-Jiménez, O. (4) 793-804

Okun, M., see Price, C.C. (4) 893-905

Okun, M.S., see Ellis, C. (2) 403-411

Okun, M.S., see Hassan, A. (2) 313-319

Oliveira-Filho, J., see Almeida, L.R.S. (4) 855-864

Oortwijn, W., see Canoy, M. (3) 575-580

Palladino, R., see Moccia, M. (4) 913-924

Pani, A., see Jiao, Y. (2) 389-401

Panisset, M., see Béland, S.-G. (4) 805-811

Panisset, M., see Daneault, J.-F. (1) 85-93

Parashos, S.A., J. Elm, J.T. Boyd, K.L. Chou, L. Dai, Z. Mari, J.C. Morgan, L. Sudarsky and C.L. Wielinski, Validation of an Ambulatory Capacity Measure in Parkinson Disease: A Construct Derived from the Unified Parkinson’s Disease Rating Scale (1) 67-73

Paul, S.S., see Almeida, L.R.S. (4) 855-864

Pavlovic, D., see Yang, P. (4) 821-836

Pekkonen, E., see Scheperjans, F. (2) 255-262

Peña, J., see Lucas-Jiménez, O. (4) 793-804

Pereira, J.B., see Skogseth, R.E. (4) 783-792

Perju-Dumbrava, L., see Pirker, S. (4) 907-912

Peterson, E.L., see Silbergleit, A.K. (3) 517-524

Phibbs, F.T., see Tramontana, M.G. (1) 151-163

Piazza, S.J., see Sterling, N.W. (1) 141-150

Picillo, M., see Moccia, M. (4) 913-924

Pinto, A., see Domingos, J.M. (3) 453-469

Pirker, S., L. Perju-Dumbrava, G.G. Kovacs, T. Traub-Weidinger and W. Pirker, Progressive Dopamine Transporter Binding Loss in Autopsy-Confirmed Corticobasal Degeneration (4) 907-912

Pirker, W., see Pirker, S. (4) 907-912

Pirogovsky-Turk, E., J.V. Filoteo, I. Litvan and D.L. Harrington, Structural MRI Correlates of Episodic Memory Processes in Parkinson’s Disease Without Mild Cognitive Impairment (4) 971-981

Poewe, W., see Mahlknecht, P. (4) 681-697

Postuma, R.B., see Béland, S.-G. (4) 805-811

Powell, J.J., see Caviness, J.N. (1) 117-124

Preterre, C., A.-G. Corbillé, G. Balloy, F. Letournel, M. Neunlist and P. Derkinderen, Optimizing Western Blots for the Detection of Endogenous α-Synuclein in the Enteric Nervous System (4) 765-772

Price, C.C., S.-A. Levy, J. Tanner, C. Garvan, J. Ward, F. Akbar, D. Bowers, M. Rice and M. Okun, Orthopedic Surgery and Post-Operative Cognitive Decline in Idiopathic Parkinson’s Disease: Considerations from a Pilot Study (4) 893-905

Price, C.C., see Cohen, M.L. (4) 961-970

Prodoehl, J., see Lamotte, G. (1) 21-41

Rafferty, M.R., see Lamotte, G. (1) 21-41

Rahimi, J., I. Milenkovic and G.G. Kovacs, Patterns of Tau and α-Synuclein Pathology in the Visual System (2) 333-340

Rau, K., see Brehm, N. (3) 595-604

Ravina, B., see Simon, D.K. (4) 731-736

Reichmann, H., see Klingelhoefer, L. (3) 647-658

Reilly, R.B., see Fearon, C. (4) 925-936

Reimão, S., P.P. Lobo, D. Neutel, L.C. Guedes, M. Coelho, M.M. Rosa, J. Ferreira, D. Abreu, N. Gonçalves, C. Morgado, R.G. Nunes, J. Campos and J.J. Ferreira, Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson’s disease (3) 561-567

Reish, H.E.A. and D.G. Standaert, Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease (1) 1-19

Reizine, N., see Westbay, L.C. (3) 497-504

Reynolds, G.O., see Seichepine, D.R. (1) 75-83

Rice, M., see Price, C.C. (4) 893-905

Richard, I.H., see Dorsey, E.R. (3) 505-515

Rigby, H., see Lin, T.P. (1) 125-130

Riggare, S., see Serrano, J.A. (1) 187-196

Rizzieri, A., see Dorsey, E.R. (3) 505-515

Robledo, I., see Mathur, S. (2) 263-268

Rocker, C., L. Cappelletti, C. Marshall, C.C. Meunier, D.W. Brooks, T. Sherer and S. Chowdhury, Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial Finder (1) 55-66

Rocker, C., see Dorsey, E.R. (3) 505-515

Rodríguez-Violante, M., see Alvarado-Bolaños, A. (3) 541-548

Rolinski, M., see Lawton, M. (2) 269-279

Romero, K., see Stephenson, D. (3) 581-594

Rosa, M.M., see Reimão, S. (3) 561-567

Rose, T.C., see Bettiol, S.S. (3) 425-442

Rosenbek, J.C., see Ellis, C. (2) 403-411

Ross, G.W., see Simon, D.K. (4) 731-736

Rothi, L.J.G., see Ellis, C. (2) 403-411

Rubens, R., see Nausieda, P.A. (4) 837-845

Ruffman, C., see Lawton, M. (2) 269-279

Sabbagh, M.N., see Caviness, J.N. (1) 117-124

Sadikot, A.F., see Daneault, J.-F. (1) 85-93

Saha, R., see Matthews, H. (3) 533-539

Salomon, R.M., see Tramontana, M.G. (1) 151-163

Samuel, M., see Ughratdar, I. (3) 483-496

Santos, A.T., see Ferreira, J.J. (2) 281-290

Sardina, M., see Cattaneo, C. (3) 475-481

Schee, J.P., see Tan, A.H. (4) 865-879

Scheperjans, F., E. Pekkonen, S. Kaakkola and P. Auvinen, Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota? (2) 255-262

Schmidt, P., see Hassan, A. (2) 313-319

Schneider, C.B., see Ma, J.K.-Y. (2) 291-299

Schneider, J., see Bega, D. (4) 773-782

Schrader, C., see Münte, T.F. (3) 613-620

Schwab, N.A., see Cohen, M.L. (4) 961-970

Schwarz, H., see Dorsey, E.R. (3) 505-515

Scullin, M.K., J.A. Fairley, L.M. Trotti, F.C. Goldstein, S.A. Factor and D.L. Bliwise, Sleep Correlates of Trait Executive Function and Memory in Parkinson’s Disease (1) 49-54

Seichepine, D.R., S. Neargarder, S. Davidsdottir, G.O. Reynolds and A. Cronin-Golomb, Side and Type of Initial Motor Symptom Influences Visuospatial Functioning in Parkinson’s Disease (1) 75-83

Semah, F., see Tard, C. (3) 569-574

Seppi, K., see Mahlknecht, P. (4) 681-697

Serrano, J.A., F. Larsen, T. Isaacs, H. Matthews, J. Duffen, S. Riggare, F. Capitanio, J.J. Ferreira, J. Domingos, W. Maetzler, H. Graessner and SENSE-PARK Consortium, Participatory Design in Parkinson’s Research with Focus on the Symptomatic Domains to be Measured (1) 187-196

Serrano, J.A., see Ferreira, J.J. (2) 281-290

Shaham, N., see Sterling, N.W. (1) 141-150

Sharma, S., see Simon, D.K. (4) 731-736

Sherer, T., see Dorsey, E.R. (3) 505-515

Sherer, T., see Rocker, C. (1) 55-66

Sherrington, C., see Almeida, L.R.S. (4) 855-864

Shill, H.A., see Caviness, J.N. (1) 117-124

Shine, J.M., see Hall, J.M. (4) 881-891

Sierra, M., S. Carnicella, A.P. Strafella, A. Bichon, E. Lhommée, A. Castrioto, S. Chabardes, S. Thobois and P. Krack, Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors (3) 625-636

Silbergleit, A.K., P.A. LeWitt, E.L. Peterson and G.M. Gardner, Quantitative Analysis of Voice in Parkinson Disease Compared to Motor Performance: A Pilot Study (3) 517-524

Simon, D.K., T. Simuni, J. Elm, J. Clark-Matott, A.K. Graebner, L. Baker, S.R. Dunlop, M. Emborg, C. Kamp, J.C. Morgan, G.W. Ross, S. Sharma, B. Ravina and On behalf of the NINDS NET-PD Investigators, Peripheral Biomarkers of Parkinson’s Disease Progression and Pioglitazone Effects (4) 731-736

Simon-Tov, S., T. Dinur, N. Giladi, A. Bar-Shira, M. Zelis, A. Zimran and D. Elstein, Color Discrimination in Patients with Gaucher Disease and Parkinson Disease (3) 525-531

Simuni, T., see Bega, D. (4) 773-782

Simuni, T., see Hassan, A. (2) 313-319

Simuni, T., see Lamotte, G. (1) 21-41

Simuni, T., see Simon, D.K. (4) 731-736

Singer, C., see Nausieda, P.A. (4) 837-845

Skogseth, R.E., K. Bronnick, J.B. Pereira, B. Mollenhauer, D. Weintraub, T. Fladby and D. Aarsland, Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson’s Disease (4) 783-792

Slevin, J.T., H.H. Fernandez, C. Zadikoff, C. Hall, S. Eaton, J. Dubow, K. Chatamra and J. Benesh, Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson’s Disease Patients (1) 165-174

Smeyne, R.J., see Jiao, Y. (2) 389-401

Smith, L.A., see Bettiol, S.S. (3) 425-442

Smith, S.T., see Brodie, M.A.D. (1) 105-116

Sollinger, S., see Ferreira, J.J. (2) 281-290

Song, Y., see Tramontana, M.G. (1) 151-163

Soo, S.K., see Tan, A.H. (4) 865-879

Spiegel, J., see Nausieda, P.A. (4) 837-845

Spiro, A.S., see Abbott, S.K. (1) 175-185

Stamford, J., see Mathur, S. (2) 263-268

Stamford, J., see Matthews, H. (3) 533-539

Standaert, D.G., see Reish, H.E.A. (1) 1-19

Stark, Y., see Stephenson, D. (3) 581-594

Starkstein, S., see Egan, S.J. (3) 443-451

Stephenson, D., M.T. Hu, K. Romero, K. Breen, D. Burn, Y. Ben-Shlomo, A. Bhattaram, M. Isaac, C. Venuto, K. Kubota, M.A. Little, S. Friend, S. Lovestone, H.R. Morris, D. Grosset, M. Sutherland, J. Gallacher, C. Williams-Gray, L.J. Bain, E. Avilés, K. Marek, A.W. Toga, Y. Stark, M.F. Gordon and S. Ford, Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease (3) 581-594

Sterling, N.W., J.P. Cusumano, N. Shaham, S.J. Piazza, G. Liu, L. Kong, G. Du, M.M. Lewis and X. Huang, Dopaminergic Modulation of Arm Swing During Gait Among Parkinson’s Disease Patients (1) 141-150

Storch, A., see Ma, J.K.-Y. (2) 291-299

Strafella, A.P., see Fasano, A. (2) 241-254

Strafella, A.P., see Sierra, M. (3) 625-636

Stroupe, K.T., see Westbay, L.C. (3) 497-504

Sudarsky, L., see Parashos, S.A. (1) 67-73

Sullivan, K.L., J.A. Mortimer, W. Wang, T.A. Zesiewicz, H.J. Brownlee and A.R. Borenstein, Occupational Characteristics and Patterns as Risk Factors for Parkinson’s Disease: A Case Control Study (4) 813-820

Sutherland, M., see Stephenson, D. (3) 581-594

Swallow, D.M.A., see Malek, N. (4) 947-959

Synek, B., see Yang, P. (4) 821-836

Tan, A.H., C.T. Tan, C. Marras, K.W. Loh, N.W.W. Ho, Q.H. Lim, P.W. Tan, C.C. Lim, Y.W. Cheong, S.T. Kong, J.P. Schee, K.H. Tan, S.K. Soo, C. Vanderschaaf, S.L.H. Lew, U.A. Mahamad, K.J. Goh, H.S. Yong and S.-Y. Lim, Knowledge of Parkinson’s Disease in a Multiethnic Urban Asian Setting (4) 865-879

Tan, C.T., see Tan, A.H. (4) 865-879

Tan, K.H., see Tan, A.H. (4) 865-879

Tan, P.W., see Tan, A.H. (4) 865-879

Tanner, J., see Price, C.C. (4) 893-905

Tard, C., A. Delval, A. Duhamel, C. Moreau, D. Devos, L. Defebvre and K. Dujardin, Specific Attentional Disorders and Freezing of Gait in Parkinson’s Disease (2) 379-387

Tard, C., F. Demailly, A. Delval, F. Semah, L. Defebvre, K. Dujardin and C. Moreau, Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson’s Disease (3) 569-574

Taylor, J.-P., see Yarnall, A.J. (4) 743-747

Tessitore, A., see Fasano, A. (2) 241-254

Thobois, S., see Sierra, M. (3) 625-636

Thoms, A., see Ferreira, J.J. (2) 281-290

Thordardottir, B., see Nilsson, M.H. (4) 983-992

Tobin, G., see Mitra, R. (2) 301-311

Toga, A.W., see Stephenson, D. (3) 581-594

Torres, E.R., see Magen, I. (3) 669-680

Tramontana, M.G., A.L. Molinari, P.E. Konrad, T.L. Davis, S.A. Wylie, J.S. Neimat, A.T. May, F.T. Phibbs, P. Hedera, C.E. Gill, R.M. Salomon, L. Wang, Y. Song and D. Charles, Neuropsychological Effects of Deep Brain Stimulation in Subjects with Early Stage Parkinson’s Disease in a Randomized Clinical Trial (1) 151-163

Traub-Weidinger, T., see Pirker, S. (4) 907-912

Trotti, L.M., see Scullin, M.K. (1) 49-54

Turner, C., see Yang, P. (4) 821-836

Ughratdar, I., M. Samuel and K. Ashkan, Technological Advances in Deep Brain Stimulation (3) 483-496

Ullén, S., see Jonasson, S.B. (2) 341-349

Valenca, G.T., see Almeida, L.R.S. (4) 855-864

van de Warrenburg, B.P., see Zach, H. (4) 727-729

van der Eijk, M., B.R. Bloem, F.A.P. Nijhuis, J. Koetsenruijter, H.J.M. Vrijhoef, M. Munneke, M. Wensing and M.J. Faber, Multidisciplinary Collaboration in Professional Networks for PD A Mixed-Method Analysis (4) 937-945

van Vliet, V., see Allen, N.E. (2) 229-239

van Wegen, E.E.H., see Zhao, Y. (2) 369-378

van Wezel, R.J.A., see Zhao, Y. (2) 369-378

Vanderschaaf, C., see Tan, A.H. (4) 865-879

Venuto, C., see Stephenson, D. (3) 581-594

Vrijhoef, H.J.M., see van der Eijk, M. (4) 937-945

Wagner, J.D., see Dorsey, E.R. (3) 505-515

Waldvogel, H., see Yang, P. (4) 821-836

Wallon, D., see Le Goff, F. (1) 95-104

Walton, C.C., see Hall, J.M. (4) 881-891

Wang, L., see Tramontana, M.G. (1) 151-163

Wang, W., see Sullivan, K.L. (4) 813-820

Ward, J., see Price, C.C. (4) 893-905

Weaver, F.M., see Westbay, L.C. (3) 497-504

Weber, P., see Ferreira, J.J. (2) 281-290

Weerdesteyn, V., see Nonnekes, J. (1) 43-47

Weintraub, D., see Skogseth, R.E. (4) 783-792

Wensing, M., see van der Eijk, M. (4) 937-945

Westbay, L.C., L. Cao, I. Burnett-Zeigler, N. Reizine, B. Barton, D. Ippolito, F.M. Weaver and K.T. Stroupe, Mental Health-Related Healthcare Use Following Bilateral Deep Brain Stimulation For Parkinson’s Disease (3) 497-504

Wielinski, C.L., see Parashos, S.A. (1) 67-73

Wilkinson, L., see Williams, I.A. (2) 321-331

Williams, I.A., L. Wilkinson, P. Limousin and M. Jahanshahi, Load-Dependent Interference of Deep Brain Stimulation of the Subthalamic Nucleus with Switching from Automatic to Controlled Processing During Random Number Generation in Parkinson’s Disease (2) 321-331

Williams, N.M., see Malek, N. (4) 947-959

Williams-Gray, C., see Stephenson, D. (3) 581-594

Winder, M., see Mitra, R. (2) 301-311

Wolfson, C., see Béland, S.-G. (4) 805-811

Wood, N., see Malek, N. (4) 947-959

Wu, S.S., see Hassan, A. (2) 313-319

Wylie, S.A., see Tramontana, M.G. (1) 151-163

Yang, K.M., see Kelm-Nelson, C.A. (4) 749-763

Yang, P., D. Pavlovic, H. Waldvogel, M. Dragunow, B. Synek, C. Turner, R. Faull and J. Guan, String Vessel Formation is Increased in the Brain of Parkinson Disease (4) 821-836

Yarnall, A.J., R.A. Lawson, G.W. Duncan, D.P. Breen, T.K. Khoo, D. Brooks, R.A. Barker, J.-P. Taylor and D.J. Burn, Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson’s Disease? (4) 743-747

Yong, H.S., see Tan, A.H. (4) 865-879

Zach, H., M. Dirkx, B.R. Bloem and R.C. Helmich, The Clinical Evaluation of Parkinson’s Tremor (3) 471-474

Zach, H., W.L.J. Gerrits, B.P. van de Warrenburg and B.R. Bloem, A Positive ‘Pointing Test’ in a Parkinson’s Disease Patient (4) 727-729

Zadikoff, C., see Slevin, J.T. (1) 165-174

Zelis, M., see Simon-Tov, S. (3) 525-531

Zesiewicz, T.A., see Sullivan, K.L. (4) 813-820

Zhang, Y., see Bega, D. (4) 773-782

Zhao, Y., T. Heida, E.E.H. van Wegen, B.R. Bloem and R.J.A. van Wezel, E-health Support in People with Parkinson’s Disease with Smart Glasses: A Survey of User Requirements and Expectations in the Netherlands (2) 369-378

Zijlmans, J.C., see Haaxma, C.A. (4) 847-853

Zimran, A., see Simon-Tov, S. (3) 525-531

Zuñiga-Ramírez, C., see Alvarado-Bolaños, A. (3) 541-548